GlycoScience Inc
Pharmaceutical Manufacturing • 
Tokyo, Japan • 1-10 Employees
Company overview
| Headquarters | Tokyo, Japan |
| Phone number | +81358408213 |
| Website | |
| NAICS | 3254 |
| SIC | 807 |
| Employees | 1-10 |
| Socials |
Key Contact at GlycoScience Inc
Shinya Miike
President & CEO
About GlycoScience Inc
Glycosaminoglycans*, i.e., hyaluronan, keratan sulfate, chondroitin sulfate, and heparin/heparan sulfate are thought be space fillers, because they are localized in extracellular matrices. In general, ordinary pharmaceutical companies do not have expertise with technology of carbohydrates including glycosaminoglycans. Since this research area is considerably different from ones of proteins and nucleic acids, it is difficult to study carbohydrates. However, nowadays, research has shown that glycosaminoglycans have a wide variety of novel cell biological activities.
GlycoScience Inc revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
GlycoScience Inc has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
GlycoScience Inc has never raised funding before.
GlycoScience Inc Tech Stack
Discover the technologies and tools that power GlycoScience Inc's digital infrastructure, from frameworks to analytics platforms.
Web servers
JavaScript libraries
JavaScript libraries
Miscellaneous
Font scripts
Portugal
United Kingdom
Ireland
United States
New Zealand
South AfricaFrequently asked questions
4.8
40,000 users
